New guidance from the UK National Institute of Health and Care Excellence (NICE) has recommended the use of Boston Scientific Corp. Rezum system to treat benign prostatic hyperplasia (BPH).
BPH is a common condition affecting about 50% of men over 60, and up to 90% of men over 85. Symptoms include frequent or urgent urination, a weak or interrupted...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?